Cloprostenol Sodium

Spécifications

55028-72-3Numéro CAS

259-439-3Numéro CE

sodium (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoateNom IUPAC

C22H28ClNaO6Formule chimique

446.9 g/molMasse molaire

Cloprostenol sodium; Estrumate; Cloprostenol sodium salt; Estroplan; Planate; DTXSID1046500; Sodium cloprostenol; 886SAV9675; ICI 80,996; DTXCID9026500; ICI-80996; 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (5Z)-rel-; Estrumate, Heifex; estroPLAN Injection; SYNCHSURE; RefChem:56482; 259-439-3; (+)-Cloprostenol sodium; 55028-72-3; 62561-03-9; D-Cloprostenol sodium salt; (+)-Cloprostenol (sodium salt); (+)-Cloprostenol (sodium); Cloprostenol sodium, (+)-; (+/-)-Cloprostenol sodium salt; (5Z)-rel-Cloprostenol Sodium; C22H28ClNaO6; ICI 80996; 81129I41BJ; sodium;(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate; Sodium (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate; Sodium;(Z)-7-[(1S,2S,3S,5R)-2-[(E,3S)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate; (+)-CLOPROSTENOL SODIUM SALT; MFCD05863539; 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, sodium salt (1:1), (5Z)-; D-Cloprostenol sodium; NCGC00165774-02; Cloprostenol sodium [USAN]; UNII-886SAV9675; Cloprostenol sodium [USAN:USP]; EINECS 259-439-3; MFCD00132875; SCHEMBL28242; MLS000028831; BML2-G09; SCHEMBL29709332; UNII-81129I41BJ; MSK8070; IFEJLMHZNQJGQU-KXXGZHCCSA-M; GLXC-25424; HMS1361O21; HMS2235O09; HMS3268J10; HMS3413C18; CLOPROSTENOL SODIUM [MART.]; EX-A1351; Sodium (5Z)-7-{(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate; Tox21_112261; CLOPROSTENOL SODIUM [USP-RS]; MSK8070-100Y; AKOS015967190; AKOS024457034; AC-6102; AT39750; FC35314; HY-107381A; CLOPROSTENOL SODIUM [GREEN BOOK]; NCGC00159550-01; (+-)-Sodium (Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(m-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate; AC-25916; CLOPROSTENOL SODIUM [USP IMPURITY]; SMR000058871; CLOPROSTENOL SODIUM [USP MONOGRAPH]; CAS-55028-72-3; CS-0133632; Cloprostenol sodium Solution in Ethanol, 100ug/mL; (+/-)-SODIUM (Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(M-CHLOROPHENOXY)-3-HYDROXY-1-BUTENYL)-3,5-DIHYDROXYCYCLOPENTYL)-5-HEPTENOATE; 5-HEPTENOIC ACID, 7-((1R,2R,3R,5S)-2-((1E,3S)-4-(3-CHLOROPHENOXY)-3-HYDROXY-1-BUTEN-1-Y))-3,5-DIHYDROXYCYCLOPENTYL)-, SODIUM SALT (1:1),(5Z)-REL-; 5-HEPTENOIC ACID, 7-(2-(4-(3-CHLOROPHENOXY)-3-HYDROXY-1-BUTENYL)-3,5-DIHYDROXYCYCLOPENTYL)-, (1A(Z),2B(1E,3R*),3.ALPHA.,5.ALPHA.)-, SODIUM SALT, (+/-)-; 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-, sodium salt, (+-)-; 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-)-; Sodium (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(1)-7-(2-(4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoate; Sodium (Z)-rel-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate; Sodium(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate; sodium;(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl]hept-5-enoateSynonymes